Zobrazeno 1 - 10
of 49
pro vyhledávání: '"E. V. Gracheva"'
Autor:
E. V. Gracheva, E. A. Starovoytova, E. S. Kulikov, N. A. Kirillova, S. V. Fedosenko, M. A. Balaganskaya, D. V. Kromka
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 19, Iss 3, Pp 298-306 (2023)
Cardiovascular disease is the most common cause of death worldwide. In this regard, there is a need to find and implement effective methods for the prevention and treatment of such diseases. Lifestyle modification is an important component of a compl
Externí odkaz:
https://doaj.org/article/c8fabf6b5a2844d1abcd7683078f0959
Publikováno v:
Неврология, нейропсихиатрия, психосоматика, Vol 12, Iss 6, Pp 42-48 (2020)
Parkinson’s disease (PD) is a disease characterized by marked phenotypic heterogeneity. The akinetic-rigid (AR) and tremor-dominant (TD) types of PD differ not only in motor manifestations, but also in the severity of non-motor symptoms, including
Externí odkaz:
https://doaj.org/article/ee1dd7b7fef5471b8d134d159d66f5ae
Autor:
Y. G. Khomenko, I. V. Miliukhina, E. V. Gracheva, G. V. Kataeva, A. A. Bogdan, E. A. Gromova, D. S. Susin
Publikováno v:
Бюллетень сибирской медицины, Vol 18, Iss 4, Pp 150-160 (2020)
Introduction. Modern neuroimaging methods allow to evaluate in vivo biochemical processes in the brain. Such methods include magnetic resonance spectroscopy (MRS) and positron emission tomography (PET). While PET is the “golden standard” in asses
Externí odkaz:
https://doaj.org/article/6c4f119e5cbf4b468a55db33c651e236
Autor:
T. S. Usenko, K. A. Senkevich, A. I. Bezrukova, G. V. Baydakova, K. S. Basharova, A. S. Zhuravlev, E. V. Gracheva, A. V. Kudrevatykh, I. V. Miliukhina, I. V. Krasakov, L. A. Khublarova, I. V. Fursova, D. V. Zakharov, A. A. Timofeeva, Y. A. Irishina, E. I. Palchikova, N. M. Zalutskaya, A. K. Emelyanov, E. Y. Zakharova, S. N. Pchelina
Publikováno v:
Molecular Neurobiology. 59:2277-2287
Autor:
E. V. Gracheva, I. V. Miliukhina
Publikováno v:
Neuroscience and Behavioral Physiology. 51:423-429
Objective. To assess the efficacy of memantine hydrochloride in correcting gait disturbances in patients with Parkinson’s disease (PD). Materials and methods. The study group consisted of 30 patients with PD in whom standard antiparkinsonism therap
Autor:
D. G. Kulabukhova, L. A. Garaeva, A. K. Emelyanov, K. A. Senkevich, E. V. Gracheva, I. V. Miliukhina, E. Y. Varfolomeeva, A. A. Timofeeva, A. L. Schwartsman, T. A. Shtam, S. N. Pchelina
Publikováno v:
Molecular Biology. 55:297-303
Publikováno v:
Nevrologiâ, Nejropsihiatriâ, Psihosomatika, Vol 12, Iss 6, Pp 42-48 (2020)
Parkinson’s disease (PD) is a disease characterized by marked phenotypic heterogeneity. The akinetic-rigid (AR) and tremor-dominant (TD) types of PD differ not only in motor manifestations, but also in the severity of non-motor symptoms, including
Autor:
T S, Usenko, K A, Senkevich, A I, Bezrukova, G V, Baydakova, K S, Basharova, A S, Zhuravlev, E V, Gracheva, A V, Kudrevatykh, I V, Miliukhina, I V, Krasakov, L A, Khublarova, I V, Fursova, D V, Zakharov, A A, Timofeeva, Y A, Irishina, E I, Palchikova, N M, Zalutskaya, A K, Emelyanov, E Y, Zakharova, S N, Pchelina
Publikováno v:
Molecular neurobiology. 59(4)
The synucleinopathies are a group of neurodegenerative diseases characterized by the oligomerization of alpha-synuclein protein in neurons or glial cells. Recent studies provide data that ceramide metabolism impairment may play a role in the pathogen
Autor:
E V Gracheva, Irina Miliukhina
Publikováno v:
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 120(8)
To assess the efficacy of memantine hydrochloride in the treatment of GD in PD patients.Patients of the main group (The increase in MMSE scores, improvement in gait cycle phases ratio and increase of cadence according to computerized gait analysis we
Autor:
D G, Kulabukhova, L A, Garaeva, A K, Emelyanov, K A, Senkevich, E V, Gracheva, I V, Miliukhina, E Y, Varfolomeeva, A A, Timofeeva, A L, Schwartsman, T A, Shtam, S N, Pchelina
Publikováno v:
Molekuliarnaia biologiia. 55(2)
Parkinson's disease (PD) is the second most common neurodegenerative disorder. Alpha-synuclein misfolding and aggregation resulting in neurototoxicity is a hallmark of PD. The prion properties of alpha-synuclein are still under discussion. Exosomes (